...
search icon
vygr-img

Voyager Therapeutics Inc Share Price

VYGR
NSQ
$3.92
-$0.4
(-9.26%)
1D
Industry: Biotechnology Sector: Health Care

Voyager Therapeutics Inc Analyst Forecast

Voyager Therapeutics Inc Share Price Chart

Voyager Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$257.47M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.86M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.39
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.65 L
$5.55 H
$3.92

About Voyager Therapeutics Inc, Common Stock

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts. more

Industry: BiotechnologySector: Health Care

Voyager Therapeutics Inc Stock Returns

Time FrameVYGRSectorS&P500
1-Week Return-21.6%-1.4%-1.21%
1-Month Return14.96%-4.04%-2.04%
3-Month Return-7.98%-1.81%-0.35%
6-Month Return-7.98%10.07%1.5%
1-Year Return0.77%2.89%17.99%
3-Year Return-50.51%19.98%70.94%
5-Year Return-28.21%31.43%68.43%
10-Year Return-62.88%127.77%227.66%

Voyager Therapeutics Inc Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue37.41M40.91M250.01M80.00M40.37M[{"date":"2021-12-31","value":14.97,"profit":true},{"date":"2022-12-31","value":16.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":32,"profit":true},{"date":"2025-12-31","value":16.15,"profit":true}]
Cost of Revenue73.79M6.19M92.17M4.73M4.06M[{"date":"2021-12-31","value":80.05,"profit":true},{"date":"2022-12-31","value":6.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":5.13,"profit":true},{"date":"2025-12-31","value":4.4,"profit":true}]
Gross Profit37.41M40.91M157.84M80.00M36.31M[{"date":"2021-12-31","value":23.7,"profit":true},{"date":"2022-12-31","value":25.92,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":50.69,"profit":true},{"date":"2025-12-31","value":23.01,"profit":true}]
Gross Margin100.00%100.00%63.13%100.00%89.94%[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.13,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":89.94,"profit":true}]
Operating Expenses111.03M91.74M35.82M163.29M168.16M[{"date":"2021-12-31","value":66.03,"profit":true},{"date":"2022-12-31","value":54.56,"profit":true},{"date":"2023-12-31","value":21.3,"profit":true},{"date":"2024-12-31","value":97.1,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income(73.62M)(50.84M)122.01M(83.29M)(131.84M)[{"date":"2021-12-31","value":-60.34,"profit":false},{"date":"2022-12-31","value":-41.66,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-68.26,"profit":false},{"date":"2025-12-31","value":-108.06,"profit":false}]
Total Non-Operating Income/Expense2.03M6.24M23.45M37.28M22.89M[{"date":"2021-12-31","value":5.45,"profit":true},{"date":"2022-12-31","value":16.73,"profit":true},{"date":"2023-12-31","value":62.89,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":61.39,"profit":true}]
Pre-Tax Income(71.20M)(46.39M)133.74M(64.34M)(119.58M)[{"date":"2021-12-31","value":-53.24,"profit":false},{"date":"2022-12-31","value":-34.69,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-48.11,"profit":false},{"date":"2025-12-31","value":-89.41,"profit":false}]
Income Taxes(5.17M)16.00K1.41M665.00K144.00K[{"date":"2021-12-31","value":-366.83,"profit":false},{"date":"2022-12-31","value":1.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":47.23,"profit":true},{"date":"2025-12-31","value":10.23,"profit":true}]
Income After Taxes(66.03M)(46.41M)132.33M(65.00M)(119.72M)[{"date":"2021-12-31","value":-49.9,"profit":false},{"date":"2022-12-31","value":-35.07,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-49.12,"profit":false},{"date":"2025-12-31","value":-90.47,"profit":false}]
Income From Continuous Operations(71.20M)(46.41M)132.33M(65.00M)(119.72M)[{"date":"2021-12-31","value":-53.8,"profit":false},{"date":"2022-12-31","value":-35.07,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-49.12,"profit":false},{"date":"2025-12-31","value":-90.47,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income(66.03M)(46.41M)132.33M(65.00M)(119.72M)[{"date":"2021-12-31","value":-49.9,"profit":false},{"date":"2022-12-31","value":-35.07,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-49.12,"profit":false},{"date":"2025-12-31","value":-90.47,"profit":false}]
EPS (Diluted)(1.90)(1.22)3.09(1.13)(2.04)[{"date":"2021-12-31","value":-61.49,"profit":false},{"date":"2022-12-31","value":-39.48,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-36.57,"profit":false},{"date":"2025-12-31","value":-66.02,"profit":false}]

Voyager Therapeutics Inc Ratios

Voyager Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

VYGR
Cash Ratio 7.40
Current Ratio 7.64

Voyager Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VYGR
ROA (LTM) -24.86%
ROE (LTM) -48.29%

Voyager Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VYGR
Debt Ratio Lower is generally better. Negative is bad. 0.22
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.78

Voyager Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VYGR
Trailing PE NM
Forward PE NM
P/S (TTM) 6.38
P/B 1.31
Price/FCF NM
EV/R 2.42
EV/Ebitda 2.59
PEG NM

FAQs

What is Voyager Therapeutics Inc share price today?

Voyager Therapeutics Inc (VYGR) share price today is $3.92

Can Indians buy Voyager Therapeutics Inc shares?

Yes, Indians can buy shares of Voyager Therapeutics Inc (VYGR) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VYGR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Voyager Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Voyager Therapeutics Inc (VYGR) via the Vested app. You can start investing in Voyager Therapeutics Inc (VYGR) with a minimum investment of $1.

How to invest in Voyager Therapeutics Inc shares from India?

You can invest in shares of Voyager Therapeutics Inc (VYGR) via Vested in three simple steps:

  • Click on Sign Up or Invest in VYGR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Voyager Therapeutics Inc shares
What is Voyager Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Voyager Therapeutics Inc (VYGR) is $5.55. The 52-week low price of Voyager Therapeutics Inc (VYGR) is $2.65.

What is Voyager Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Voyager Therapeutics Inc (VYGR) is

What is Voyager Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Voyager Therapeutics Inc (VYGR) is 1.31

What is Voyager Therapeutics Inc dividend yield?

The dividend yield of Voyager Therapeutics Inc (VYGR) is 0.00%

What is the Market Cap of Voyager Therapeutics Inc?

The market capitalization of Voyager Therapeutics Inc (VYGR) is $257.47M

What is Voyager Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Voyager Therapeutics Inc is VYGR

How Can Investors Use Voyager Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Voyager Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Voyager Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Voyager Therapeutics Inc shares for Indian investors?

When investing in Voyager Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Voyager Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Voyager Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Voyager Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Voyager Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top